Cosmos Health Inc (COSM) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Cosmos Health Inc   (NASDAQ: COSM)

Select the Financial Report: Select the Period:


Description of Cosmos Health Inc's Business Segments
The registrant's reportable operating business segments are the wholesale sector, the pharmaceutical manufacturing sector, and the nutraceuticals and pharmaceuticals sector, as defined by ASC 280. The Chief Executive Officer uses financial information from these segments for resource allocation and performance evaluation. An additional "Other" category includes corporate expenses incurred by the Group's parent entity, Cosmos Health Inc., such as costs related to SEC legal and compliance matters, executive compensation, audit and review fees, and other corporate overhead expenses. Financial data for these segments is presented for the years ended December 31, 2025, and 2024, including revenues, costs, expenses, and segment profits or losses.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Cosmos Health Inc Revenues by Segments
 

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Total 18.99 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Total 28.76 % 5.9 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -6.09 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Total - -




Annual Report on Cosmos Health Inc Divisions, Sales by Country

 
Greece   Greece Segment contribution to total sales 97.33 % of total Revenue
Albania   Albania Segment contribution to total sales 0.17 % of total Revenue
UK   UK Segment contribution to total sales 1.65 % of total Revenue
Cyprus   Cyprus Segment contribution to total sales 0.31 % of total Revenue
Other   Other Segment contribution to total sales 0 % of total Revenue
Wholesale   Wholesale Segment contribution to total sales 90.88 % of total Revenue
Pharma manufacturing   Pharma manufacturing Segment contribution to total sales 2.59 % of total Revenue
Nutraceuticals and Pharmaceuticals   Nutraceuticals and Pharmaceuticals Segment contribution to total sales 6.53 % of total Revenue
SKOPJE North Macedonia   SKOPJE North Macedonia Segment contribution to total sales 0.03 % of total Revenue
Croatia   Croatia Segment contribution to total sales 0.07 % of total Revenue
Bulgaria   Bulgaria Segment contribution to total sales 0.05 % of total Revenue
UAE   UAE Segment contribution to total sales 0.39 % of total Revenue
United States   United States Segment contribution to total sales 0 % of total Revenue


Twelve months ended 2025
COSM s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Total 65.27 100 %
Greece 63.53 97.33 %
Albania 0.11 0.17 %
UK 1.08 1.65 %
Cyprus 0.20 0.31 %
Other 0.00 0 %
Wholesale 59.32 90.88 %
Pharma manufacturing 1.69 2.59 %
Nutraceuticals and Pharmaceuticals 4.26 6.53 %
SKOPJE North Macedonia 0.02 0.03 %
Croatia 0.05 0.07 %
Bulgaria 0.04 0.05 %
UAE 0.25 0.39 %
United States 0.00 0 %


Twelve months ended 2025
COSM s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -19.14 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 19.93 % -
Greece 20.01 % -
UK 26.71 % -
Cyprus 10.98 % -
Wholesale 14.97 % -
Pharma manufacturing 95.18 % -
Nutraceuticals and Pharmaceuticals 116.68 % -
Croatia -1.97 % -
Bulgaria -46.91 % -
UAE -26.37 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.